are now
Press Release
NEOMED-LABS and Public Health England Announce a Strategic Agreement
June 27, 2019 | Press Release
Laval, Quebec and Porton, United Kingdom, June 27 2019 – NEOMED-LABS and Public Health England’s (PHE) National Infection Service are […]
NEOMED-LABS / Pacific Biomarkers Strengthens its Immunology Franchise by Acquiring PAIRimmune
June 6, 2019 | Press Release
LAVAL, QC, June 6, 2019 – The recently merged NEOMED-LABS / Pacific Biomarkers (NLPBI), a leading immunology centric service provider specialized […]
Timothy McGrath Appointed Chief Operating Officer of Newly Merged NEOMED-LABS / Pacific Biomarkers
March 28, 2019 | Press Release
LAVAL, QC, and SEATTLE, WA, March 28, 2019 – The newly merged NEOMED-LABS / Pacific Biomarkers, an immunology centric service […]
Ampersand Capital Partners Acquires Pacific Biomarkers and Merges Company with NEOMED-LABS
November 19, 2018 | Press Release
WELLESLEY, MA, LAVAL, QC, and SEATTLE, WA, November 19, 2018 - Ampersand Capital Partners announced today that it has completed […]
FDA Qualifies Safety Biomarker Panel Developed and Validated by Pacific Biomarkers for Kidney Injury
September 24, 2018 | Press Release
SEATTLE, WASHINGTON, November 5, 2018 – The U.S. Food and Drug Administration (FDA), announced that the qualification of the Predictive […]